SEC Form 4 · accession 0001562180-18-002680
Syndax Pharmaceuticals Inc · SNDX
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Dennis Podlesak
Director
Period of report
May 23, 2018
Accepted (ET)
May 25, 2018 · 8:59 am EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001395937
Table I — non-derivative securities
No Table I lines on this filing.
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock Option (Right to Buy) | $8.93 | May 23, 2018 | A | 14,000 | A | May 23, 2019 | May 23, 2028 | Common Stock | 14,000 | 14,000 | D |